Anticipating Cytopenia: In Vitro Methods for Hematotoxicity Testing
The screening of novel compounds to predict potential toxicity to the hematopoietic system (i.e., hematotoxicity) is an important step in drug development. This webinar discusses the importance of hematotoxicity testing in drug development, reviews methods for in vitro assay standardization, and explores the use of both colony-forming unit (CFU) assays and lineage-specific liquid culture-based assays as tools for in vitro drug screening.
Publish Date: May 26, 2016
Views: 0
Related Multimedia
-
1:52Contract Assay Services at STEMCELL Technologies Inc
Publish Date: October 07, 2015 -
36:59Derivation of Metabolically Active Hepatocytes from Human Pluripotent Stem Cells
Publish Date: July 16, 2013 -
39:40Customizing the Hematopoietic CFC Assay In Drug Development
Publish Date: October 04, 2013 -
40:56A Guide to Erythropoiesis - EPO Signaling and Erythroid Development
Publish Date: March 22, 2011
Explore Our Products
-
Serum-free medium and supplement for the measurement of drug toxicity on erythroid cells -
Serum-free medium and supplement for the measurement of drug toxicity on myeloid cells -
Serum-free medium and supplement for the measurement of drug toxicity on megakaryocytes